SeneX is a company targeting chronic inflammation and aging through metabolic gene therapy and stopping senescence. SeneX's core technology is out licensed from the Icahn School of Medicine at Mt. Sinai.

OBC LLC is a life sciences strategy consulting firm providing part time CEO, Chief Business Officer and Crisis Management services. In addition to current ongoing engagements, OBC LLC provides strategic, corporate and business development to a variety of public and private clients.

Acuity Bio IncAcuity Bio is a concept-proven (results in animal models) combination medical device company combining FDA approved products to create a new therapeutic platform in the oncology space.

Tribiotica LLCA part of NorthShore Innoventures, Tribiotica is an immune oncology company. Tribiotica has a unique technology to produce new markers specifically on tumor cells, with genetic precision.

NeuroDex is a company focusing on isolation of brain-derived exosomes, and analyzing their payload for diagnostic purposes.

Rosetta is a NASDAQ-listed microRNA therapeutic and diagnostic company operating 2 commercial CLIA and CAP labs (in Philadelphia, PA and Lake Forest, CA), and an R&D center in Israel. Key member of the global executive team and Chief Legal Officer. Conducted all business negotiations, acted as the deal “closer” as well as the CEO’s number 2, and managed the Israeli R&D and later the Princeton corporate sites. Headed the legal, intellectual property and compliance departments.Selected Achievements:• Led all legal aspects of acquisitions of various targets, resulting in the successful completion of the acquisition of Cynogen Inc. (d.b.a. PersonalizeDx) a urology-diagnostic company with over $10M in revenues from Abbott.• Co-led various financings (PIPE, Debenture, Secondary, and At-The-Market offerings) resulting in successful financings totaling over 60M USD.• Initiated and led all aspects of negotiations with a third party for out-licensing of therapeutic asset, resulting in anupfront payment as well as future royalties (total deal timeline-from initiation to closing-1 month).• Led and managed the defense in 2 proxy battles with dissident shareholders, resulting in landslide victories.• Created and led the Intellectual Property steering committee—a cross-function team which created and implementednew policies, and evaluated scientific and business merit of all intellectual property.• Played key roles in launching, commercializing, marketing, and branding of three molecular diagnostic tests.• Rebuilt the R&D, business, and G&A functions in Israel after a 90% workforce reduction.• Achieved 75% reduction in legal spend within 3 years of assuming role.

Vecoy is a seed-stage novel therapeutic company focusing on utilization of liposomes to combat viruses. Provided a wide range of services, including developing strategic plan, IP strategy, and budgeting.• Developed and implemented business plan and budget resulting in a viable development plan for potential products.• Created and implemented novel solution to leverage intellectual property and established its intellectual propertypolicy.• Developed (jointly with the CEO) research and development strategy and pipeline.

Assisted the general counsel on day-to-day activities and specific projects as well as contract management.• Implemented a contract management solution for contracts relating to in-licensed intellectual property.• Negotiated research collaboration and intellectual property licensing agreements with Israel’s largest HMO.• Led and negotiated the legal aspects of entrance into a joint industry-academia consortium under the Israeli ChiefScientist (partially funded by the Israeli Office of the Chief Scientist).

Securities, financial market and M&A attorney